Yield10 Bioscience Announces Fourth Quarter and Full Year 2023 Financial Results

-Granted global commercial license to Vision Bioenergy for Camelina addressing the biofuel market-Advanced regulatory and seed scale-up program for omega-3 Camelina-E3902 oil trait in Camelina cleared by regulatory authority for planting in Canada-Management will host a conference call today at 4:30 p.m. (ET) to review financial results and provide a corporate update WOBURN, Mass., April 01, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricult

Related Keywords

United States ,Canada ,Russia ,Chile ,Ukraine ,Canadian ,America ,Lynneh Brum , ,Us Environmental Protection Agency ,Bioenergy Oilseeds ,Biotechnology Regulatory Services ,Facebook ,Michigan State University ,Canadian Food Inspection Agency ,Plant Biosafety Office ,Exchange Commission ,Nasdaq ,Securities Exchange ,Oilseeds Inc ,Twitter ,Bioscience Inc ,Linkedin ,Vision Bioenergy ,Oliver Peoples ,Chief Executive Officer ,Vision Bioenergy Oilseeds ,Regulatory Status Review ,Regulatory Services ,North America ,Novel Trait ,Reference Event ,Securities Act ,Securities Exchange Act ,Nasdaq Stock Market ,Stockholder Equity ,Cash Flow Disclosure ,Yield10 Bioscience ,Nc ,Sustainable Products ,The Company ,